Finance

Lists
LMAT:NASDAQ
LeMaitre Vascular Inc
$82.13
-0.86%
(-0.71) 1D
$82.13
0.00% (0.00)
After hours
Closed: Aug 12, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LMAT...
Open
$81.96
High
$82.18
Low
$79.94
Mkt. cap
1.88B
Avg. vol.
384.95K
Volume
349.91K
Dividend
1.22%
Quarterly dividend
$0.25
Ex-dividend date
May 21, 2026
P/E ratio
29.69
52-wk high
$118.01
52-wk low
$78.65
EPS
$2.77
Beta
0.53
Shares outstanding
22.87M
No. of employees
651
Open
$81.96
High
$82.18
Low
$79.94
Mkt. cap
1.88B
Avg. vol.
384.95K
Volume
349.91K
Dividend
1.22%
Quarterly dividend
$0.25
Ex-dividend date
May 21, 2026
P/E ratio
29.69
52-wk high
$118.01
52-wk low
$78.65
EPS
$2.77
Beta
0.53
Shares outstanding
22.87M
No. of employees
651
News stories
From web sources and news partners
About LeMaitre Vascular Inc
CEOGeorge W Lemaitre
Employees651
Founded1983
HeadquartersBurlington, Massachusetts, United States
SectorMedical device
Websitelemaitre.com
Analyst ratings
Based on 4 analysts giving stock ratings to LMAT in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for LMAT in the last 3 months.
Highest
Current $82.13
$120.00 (+46.11%)
Average
$103.00 (+25.41%)
Lowest
$94.00 (+14.45%)
Analyst
Recommendation
Action
Price target
Projected
Date
Rick Wise
Stifel Nicolaus
Buy
Maintained
$120.00
+46.1%
08/05/2026
Michael Petusky
Barrington
Buy
Upgraded
$95.00
+15.7%
08/06/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
$94.00
+14.5%
08/05/2026
Brett Fishbin
KeyBanc
Hold
Maintained
-
-
08/05/2026
Daniel Stauder
Citizens JMP
Buy
Maintained
$127.00
+54.6%
05/06/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$135.00
+64.4%
05/06/2026
James Sidoti
Sidoti
Buy
Maintained
$132.00
+60.7%
05/06/2026
Nathan Treybeck
Wells Fargo
Hold
Maintained
$104.00
+26.6%
05/06/2026
Kyle Bauser
Roth MKM
Buy
Reiterated
$117.00
+42.5%
02/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
61.05M
64.45M
66.55M
70.38M
Cost of goods sold
17.79M
18.26M
18.16M
19.62M
Cost of revenue
17.79M
18.26M
18.16M
19.62M
Research and development expenses
3.27M
3.53M
4.06M
4.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.47M
23.82M
26.56M
25.52M
Operating expense
27.74M
27.36M
30.62M
30.36M
Total operating expenses
45.53M
45.62M
48.78M
49.98M
Operating income
15.51M
18.83M
17.78M
20.40M
Other non operating income
-306.00K
-46.00K
-127.00K
-294.00K
EBT including unusual items
22.57M
20.30M
19.67M
22.19M
EBT excluding unusual items
17.77M
20.84M
19.67M
22.19M
Income tax expense
5.21M
4.72M
3.99M
5.14M
Effective tax rate
23.09%
23.24%
20.30%
23.16%
Other operating expenses
-
-
-
-
Net income
17.36M
15.58M
15.68M
17.05M
Net profit margin
28.44%
24.18%
23.56%
24.22%
Earnings per share
0.75
0.68
0.68
0.74
Interest and investment income
3.86M
3.35M
3.32M
3.39M
Interest expense
-1.30M
-1.30M
-1.30M
-1.30M
Net interest expenses
2.57M
2.05M
2.02M
2.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
18.12M
21.44M
20.40M
23.06M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps